Volume 10, Issue 3 pp. 57-62
Review
Free Access

The pathological differential diagnosis of portal hypertension

Raouf E. Nakhleh M.D.

Corresponding Author

Raouf E. Nakhleh M.D.

Department of Pathology, Mayo Clinic Jacksonville, Jacksonville, FL

Raouf E. Nakhleh, M.D., Department of Pathology, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224. E-mail: [email protected]Search for more papers by this author
First published: 29 September 2017
Citations: 16

Potential conflict of interest: Nothing to report.

Abstract

Watch a video presentation of this article

Watch the interview with the author

The most common cause of portal hypertension is cirrhosis of the liver. Increasingly, however, liver biopsies are being done for unexplained portal hypertension. This condition is often clinically referred to as idiopathic noncirrhotic portal hypertension.1 The physiology of portal hypertension can be explained in a simplistic manner in that there is obstruction or impairment of blood flow through the portal vein. This results in increased pressure in the portal vein. When this occurs chronically, serious consequences can ensue, including the formation of esophageal varices with subsequent hemorrhage that may lead to significant morbidity and mortality. Portal hypertension is frequently determined using pressure measurements in the hepatic vein and the sinusoidal wedge pressure, which often mimics the portal pressure.2 The difference between the two is referred to as pressure gradient. The existence of a gradient, as well as the actual pressure measurement, can help in determining the level of obstruction. This is shown in Table 1.

Table 1. Portal Hypertension May Have a Number of Etiologies That May Be Categorized by the Level of Blood Flow Impairment
Location of Lesion in Fig. 1 Level of Obstruction Condition Elevated Hepatic Vein Pressure/Gradient Present
A Prehepatic

Portal vein thrombosis

Congenital venous abnormalities

No/No
B Hepatic (presinusoidal)

Hepatoportal sclerosis

Schistosomiasis

Granulomatous disease

No/No
C Hepatic (sinusoidal)

Cirrhosis

Congenital hepatic fibrosis

Steatohepatitis

Nodular regenerative hyperplasia

Amyloidosis

No/Yes
D Hepatic (postsinusoidal) Veno-occlusive disease (sinusoidal obstructive syndrome) No/Yes
E Posthepatic

Budd-Chiari syndrome

Cardiac failure

NA

Yes/No

  • The level of obstruction, the specific condition, whether the hepatic venous pressure measurement is elevated, and whether a pressure gradient exists are listed.

The causes of portal hypertension can be categorized as prehepatic, hepatic, and posthepatic. This is entirely based on the level of obstruction of the portal circulation (Table 1). The hepatic causes can also be subcategorized as presinusoidal, sinusoidal, and postsinusoidal (Fig. 1).

Details are in the caption following the image
Macroscopic and microscopic anatomy of the liver demonstrating blood flow. Level of obstruction leading to portal hypertension is identified by the letters corresponding to Table 1: (A) portal vein before entering the liver, (B) portal vein at the level of the portal tracts, (C) within the sinusoids, (D) at the juncture of the sinusoids and the central hepatic vein, and (E) hepatic vein outside the liver at the juncture of the vena cava.

Prehepatic Causes

Portal Vein Thrombosis

The most common condition leading to portal hypertension is portal vein thrombosis. This can occur because of a variety of conditions. Portal vein thrombosis is seen frequently (up to 50%) in cirrhotic native livers examined at transplantation. Portal vein thrombosis may also be seen in patients with inherited or acquired prothrombotic states. In about 25% of patients, the reason for thrombosis is not identified. Thrombosis in cirrhotic patients is likely due to abnormal hemodynamics with slowing of the portal vein flow. Inherited conditions associated with thrombosis include factor V Leiden, antithrombin, protein C, and protein S deficiencies and increased factor VII levels. The pathology of portal vein thrombosis usually manifests itself as deposition of fibrin with entrapment of red cells. With time, organization occurs with vascularization of the blood clot and deposition of collagen.

Congenital Venous Abnormalities

Congenital venous abnormalities of the portal vein system may also lead to portal hypertension. These abnormalities include partial or complete agenesis of the portal vein, abnormal branching of the portal vein, venous malposition, arteriovenous malformations, and the persistence of fetal valves.

Presinusoidal Causes

Hepatoportal Sclerosis

Hepatoportal sclerosis is a condition with multiple names. The essence of the lesion is that intrahepatic veins become sclerotic with fibrous obliteration of the lumen (Fig. 2). As shunting occurs, additional findings may include abnormally dilated portal venous branches with extension into the hepatic lobules. The cause of this lesion is not known. Multiple causes have been implicated in its development, most commonly toxicity caused by exogenous elements.

Details are in the caption following the image
Hepatoportal sclerosis demonstrated by a scarred area within the portal tract that is replacing the portal vein. A small lumen remains.

Schistosomiasis

Schistosomiasis is a well-documented cause of portal hypertension. The Schistosoma eggs embed in the portal veins and lead to obstruction of the portal vein system (Fig. 3).

Details are in the caption following the image
Schistosomiasis. (A) Portal tract demonstrating numerous calcified Schistosoma eggs imbedded within the portal vein and subsequent fibrosis . (B) Higher magnifications of calcified Schistosoma eggs.

Granulomatous Inflammation

Multiple etiologies result in granulomatous inflammation. Most will not result in portal hypertension. When granulomatous inflammation occurs primarily in the portal tracts and widely involves the liver, then portal hypertension may occur. Granulomas occur when there is a coalescence of histiocytes, often forming giant cells. Granulomas may be necrotizing or nonnecrotizing. Necrotizing granulomas typically occur with infectious causes. Other notable granulomatous conditions include sarcoidosis and primary biliary cholangitis (Fig. 4).

Details are in the caption following the image
Granulomatous hepatitis in a patient with sarcoidosis; a core biopsy demonstrates a prominent nonnecrotizing granuloma (oval) composed of coalescent macrophages with multinucleated giant cells (arrow).

Sinusoidal Causes

Common to the sinusoidal causes is the disruption of the functional sinusoidal microanatomy resulting in impaired blood flow. The disruption may occur within the sinusoidal lumen or in the space of Disse.

Cirrhosis

As stated earlier, cirrhosis is often associated with portal vein thrombosis, contributing to the portal hypertension. However, even in the absence of portal vein thrombosis, cirrhotic livers invariably cause portal hypertension as a result of altered microanatomy, resulting in significant disruption and alteration of blood flow through the liver.

Congenital Hepatic Fibrosis

Congenital hepatic fibrosis is one of a group of fibrocystic diseases of the liver that result from abnormal development of the ductal system during intrauterine development. The full-blown syndrome shows broad fibrous septae with numerous cystic abnormal ductal structures (Fig. 5). Von Meyenburg complexes are commonly seen in congenital hepatic fibrosis.

Details are in the caption following the image
Congenital hepatic fibrosis is characterized by broad fibrous septa, creating a geographic appearance with islands of hepatic parenchyma. The fibrous septa contain ductal structures that are reminiscent of bile duct hamartomas or Von Meyenburg complexes. This is in contrast with ductular proliferation, which is a physiological response to injury. Multiple bile duct hamartomas are typically present.

Steatohepatitis

Advanced stage steatohepatitis can result in portal hypertension because the disease results in deposition of collagen within the perisinusoidal space, resulting in impaired blood flow through the sinusoids. The classic features of steatohepatitis include fatty change, ballooning degeneration with the formation of Mallory's hyaline, and acute inflammatory cells.

Amyloidosis

Multiple forms of amyloidosis can occur. When amyloid deposition is limited to the periarterial location, it is unlikely to cause portal hypertension. When amyloid deposits within the sinusoids, it will result in portal hypertension. This could also occur if masses develop in the liver. The pathophysiology is that of obstruction and altered blood flow. Amyloidosis deposits as material that does not stain well with the usual hematoxylin and eosin stains (Fig. 6). Congo red stain shows amyloid as an orange color that polarizes well and produces apple-green birefringence.

Details are in the caption following the image
Amyloidosis of the liver with extensive deposition of amyloid (A) within the sinusoids compressing the hepatic plates (arrow).

Nodular Regenerative Hyperplasia

Nodular regenerative hyperplasia is a condition that is often seen in patients with collagen vascular diseases. It is thought to be due to chronic use of steroids or other anti-inflammatory treatments. Other drugs have also been implicated. The condition results in a diffusely nodular liver that does not exhibit fibrosis. Morphologically, regenerative nodules of hepatocytes are present surrounded by collapsed or atrophied hepatic plates. This is best highlighted with a reticulin stain (Fig. 7).

Details are in the caption following the image
Nodular regenerative hyperplasia. (A) Gross photograph of a liver with diffuse nodularity. (B) Hematoxylin and eosin–stained section with nodular regeneration of hepatocytes without fibrosis. (C) Reticulin stain outlining a regenerative nodule with collapse of surrounding hepatic plates.

Sinusoidal Tumor Infiltrates

There have been rare reported cases of tumor infiltrating through the sinusoids to the degree of causing portal hypertension. Examples of such occurrences include leukemia and lymphomas involving the liver.

Postsinusoidal Causes

Sinusoidal Obstructive Syndrome (Veno-occlusive Disease)

Sinusoidal obstructive syndrome typically occurs in patients with hematological malignancies after stem cell or bone marrow transplantation. It is thought to develop from prolonged conditioning chemotherapeutic agents. The lesion is an injury of the zone 3 sinusoidal lining cells at the point where the sinusoids communicate with central veins. This results in collapse of the walls of the central vein narrowing the lumen, leading to obstruction of blood flow through the sinusoids and the central veins. Over time, this lesion scars (Fig. 8).

Details are in the caption following the image
Veno-occlusive disease (sinusoidal obstructive syndrome). A trichrome stain of the liver is shown that demonstrates fibrosis as blue. Two central veins are seen with reduced lumen size. The smaller vein shows obliteration of the lumen without complete scarring (red arrow). The larger central vein demonstrates a slit-like lumen with dense fibrosis of the wall significantly reducing the lumen size (yellow arrow).

Post-Hepatic Causes

Budd-Chiari Syndrome

Budd-Chiari syndrome occurs when the hepatic vein becomes thrombosed. When this occurs acutely, there is marked dilatation and congestion of the central veins and sinusoids often with centrilobular hemorrhage. Depending on the case and extent of the lesion, thrombi may be seen in the central veins with necrosis or atrophy of the pericentral hepatocytes. Depending on the extent of injury, long-term findings will vary. They may include scarring, necrosis, and regeneration.

Cardiac Failure

Cardiac failure may occur because of any number of conditions. The differential diagnosis of cardiac failure in the setting of portal hypertension is routinely considered during cardiac transplantation workup and occasionally during renal transplant workup. Although the cardiac failure is known at the time of workup, the question posed to the pathologist is whether the portal hypertension is due to the cardiac condition or other hepatic causes. The hepatic pathology of cardiac failure manifests as marked sinusoidal dilatation and congestion. Over time, central venular fibrosis and sinusoidal fibrosis may develop.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.